Prostanoids secreted by alveolar macrophages enhance ionic currents in swine tracheal submucosal gland cells.
We examined the effect of substances released by swine alveolar macrophages (AMs) on ionic currents in airway submucosal gland cells (SGCs). AMs obtained by lavage were activated by 24-h zymosan exposure (0.1 mg/ml). Supernatant was collected and used to stimulate short-circuit current changes (DeltaI(SC)) in SGC monolayers in Ussing chambers. Dexamethasone (1 microM) or indomethacin (5 muM) during zymosan exposure of AMs reduced or abolished the supernatant-induced DeltaI(SC). Zymosan exposure induced a 5-fold increase in cyclooxygenase (COX)-2 but not COX-1 protein levels in AMs. Prostaglandin E(2) (PGE(2)) concentration in the supernatant from zymosan-activated AMs was 550 +/- 10 nM (n = 3) compared with 28 +/- 3 nM for unstimulated AMs (n = 3). PGE(2), applied serosally, induced DeltaI(SC) with an EC(50) of 15.5 +/- 1.3 nM (n = 4) and 3.6 +/- 1.8 microM (n = 3) when applied apically. Four types of endoprostanoid receptors (EP(1-4)) were detected in SGCs using Western blot. PGE(2)-induced DeltaI(SC) were inhibited by AH6809 (6-isopropoxy-9-oxoxanthene-2-carboxylic acid) but not by SC19220 (8-chloro-dibenzo[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-acetylhydrazide), suggesting that endoprostanoid (EP)(2) but not EP(1) receptors were activated by PGE(2). Pretreatment of SGCs with supernatant from zymosan-activated AMs, PGE(2), or forskolin enhanced the sensitivity to acetylcholine (ACh)-induced DeltaI(SC). PGE(2)-induced DeltaI(SC) were blocked by charybdotoxin (ChTX), chromanol 293B, or glibenclamide. ACh-induced DeltaI(SC) were only blocked by ChTX or glibenclamide. None of these blockers altered PGE(2) pretreatment-induced sensitization of ACh-induced DeltaI(SC). These results demonstrate that prostanoids released from activated AMs directly increase cystic fibrosis transmembrane conductance regulator and K(+) channel activity. ACh-induced DeltaI(SC) are also enhanced due to enhanced activation of Ca(2+)-activated K(+) channels (K(Ca)).
Liu
Huiling
H
Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, 39216, USA.
Mamoon
Abulkhair M
AM
Farley
Jerry M
JM
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D018118:Chloride Channels / Q000187:drug effects / Q000378:metabolism; D005576:Colforsin / Q000494:pharmacology; D051546:Cyclooxygenase 2 / Q000096:biosynthesis; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D015194:Diffusion Chambers, Culture; D015232:Dinoprostone / Q000378:metabolism / Q000494:pharmacology; D005088:Exocrine Glands / Q000378:metabolism*; D007213:Indomethacin / Q000494:pharmacology; D007473:Ion Channels / Q000378:metabolism*; D016676:Macrophages, Alveolar / Q000378:metabolism*; D008297:Male; D015221:Potassium Channels / Q000187:drug effects / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism* / Q000502:physiology*; D013552:Swine; D014132:Trachea / Q000378:metabolism*; D015054:Zymosan / Q000494:pharmacology
D018118:Chloride Channels; D016861:Cyclooxygenase Inhibitors; D007473:Ion Channels; D015221:Potassium Channels; D011453:Prostaglandins; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D005576:Colforsin; D003907:Dexamethasone; D015054:Zymosan; D051546:Cyclooxygenase 2; D015232:Dinoprostone; D000109:Acetylcholine; D007213:Indomethacin